The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway

Publisher: Karger

E-ISSN: 1421-9778|41|6|2503-2512

ISSN: 1015-8987

Source: Cellular Physiology and Biochemistry, Vol.41, Iss.6, 2017-05, pp. : 2503-2512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content